Better Context Better Decisions

Context counts in life sciences. The FENIX analyst team is tirelessly using its experience to put you in a position to succeed. Below, our readers without corporate access will find a wealth of contextualized life science insight ready to be purchased in the FENIX Marketplace. If our content sharing limitations are inconvenient for you, reach out to Brady for unlimited corporate, institutional, or individual access.

AACE cover image
$599
Posted in: Glucose Monitoring, Insulin Delivery May 30 | 2019FENIX Analysis: Devices Promotional Materials Post-AACE 2019Purchase Blast
medtronic cover image
$599
Posted in: Glucose Monitoring, Insulin Delivery May 23 | 2019Medtronic CY Q1 '19 (FY Q4 '19) Earnings UpdatePurchase Blast
zealand and beta bionics cover image
$599
Posted in: Glucagon, Insulin Delivery May 22 | 2019Zealand/Beta Bionics Initiate iLet In-home Closed-Loop TrialPurchase Blast
AACE cover image
$599
Posted in: Basal Insulin, Bolus Insulin, GLP-1RA + Basal May 21 | 2019FENIX Analysis: Insulin Promotional Materials Post-AACE 2019Purchase Blast
glooko cover image
$599
Posted in: Glucose Monitoring, Insulin Delivery May 21 | 2019Glooko Appoints Mark Clements as CMOPurchase Blast
fenix group cover image
$599
Posted in: Basal Insulin, Bolus Insulin, Glucose Monitoring, Insulin Delivery May 17 | 2019FDA Warns Against DIY Closed-Loop SystemsPurchase Blast
zealand cover image
$599
Posted in: Dual/triple agonist, Glucagon May 16 | 2019Zealand Q1 '19 Earnings UpdatePurchase Blast
JnJ cover image
$599
Posted in: Dual/triple agonist, SGLT2i May 15 | 2019JNJ 2019 Pharmaceutical Business ReviewPurchase Blast
lilly and merrill cover image
Free
Posted in: Dual/triple agonist, GLP-1RA May 15 | 2019Lilly oral dual agonist comments @ BAMLAccess Free Blast
FDA cover image
$599
Posted in: Basal Insulin, Bolus Insulin, GLP-1RA, GLP-1RA + Basal, Insulin Delivery May 13 | 2019FDA Issues Final Guidance on Biosimilar InterchangeabilityPurchase Blast
1 64 65 66 67 68 87

Get the Latest Analysis

Stay informed and aligned with frequent updates to keep a pulse on the industry.

If you already have an account, please log in. If you have any questions or would like to subscribe to our services, please contact Brady.